Skip to content

Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.

Anti-oxidative Influence From Pomegranate Tablets on Male Sperm Quality in Couples Undergo Infertility Treatments Due to Male Infertility.

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01918163
Acronym
Pomegranate
Enrollment
55
Registered
2013-08-07
Start date
2013-09-30
Completion date
2014-09-30
Last updated
2013-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility With Severe Oligo-terato-asteno-spermia

Keywords

pomegranate pills, male infertility, pregnancy rate, semen analysis, ROS, oxidative stress

Brief summary

Some animal studies revealed that the pomegranate juice may improve sperm quality in terms of concentration, motility and morphology, as well as in fertilization rate. Minor data is available regarding the influence on male sperm.

Detailed description

Pomegranate contains a high concentration of vitamins ( C, B1, B2, B3, B5), potassium, Magnesium , Zinc and is a good source for polyphenols .Polyphenols molecules have been found to possess antioxidant properties and may effects the expression of different genes . Recent studies indicate that among foods that contain polyphenols, juice extracted from the pomegranate has the highest concentration of measurable polyphenols . Pomegranates have shown inhibitory effect on NF-κB and the MAP kinases JNK and ERK, which are critical steps in the cascade of events leading to inflammatory response. The NF- κB pathway is activated in response to bacterial infection and initiates the inflammatory cascade, which may explain the protective effect of Pomegranates on bacterial infections.

Interventions

DIETARY_SUPPLEMENTPomegranate pills

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* TMC of less than 5 million spermatogonia in native sperm and morphology less than 4% by Kruger criteria.

Exclusion criteria

* sensitivity to Pomegranate

Design outcomes

Primary

MeasureTime frame
pregnancy24 month

Secondary

MeasureTime frameDescription
ROS (reactive oxidative stress )and Interleukins level in semen fluid12 weeksThe unit for measure the ROS are Micromolar epicatechin equivalent

Countries

Israel

Contacts

Primary ContactEinat Shalom-Paz, MD
einatshalompaz@gmail.com972544899155
Backup ContactEllenbogen Adrian, MD
ellenbogen@hy.health.gov.il973506246722

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026